Korzets, Yasmin
Yariv, Orly
Mutai, Raz
Moore, Assaf
Shochat, Tzippy
Yerushalmi, Rinat
Goldvaser, Hadar
Article History
Received: 13 June 2021
Accepted: 2 August 2021
First Online: 17 August 2021
Declarations
:
: All procedures in the study were in accordance with the ethical standards of the institutional ethics committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical Review Board: Rabin medical center institutional ethics committee, reference number: 0576-19-RMC. As data were analyzed anonymously, no informed consent was required.
: Dr. Korzets reports speaker honorarium from Roche, outside of submitted work. Dr. Moore reports speaker honorarium from Roche and Merck, all outside the submitted work. Prof. Yerushalmi reports personal fees from: Roche (Consulting, invited speaker), Pfizer (Consulting), Novartis (Consulting), Teva (Invited speaker), Medison (Invited speaker), MSD (Invited speaker), Astra-Zeneca (Invited speaker) and Novartis (Invited speaker), all outside the submitted work. Dr. Goldvaser reports personal fees from: Roche (<i>honorarium</i>), Pfizer (<i>honorarium</i>), Novartis (<i>honorarium</i> and consulting) and Oncotest (honorarium) all outside the submitted work. All other authors declare no conflict of interest.